-
1101
Women’s experiences and preferences regarding breast imaging after completing breast cancer treatment
Published 2017-02-01“…Breast imaging after cancer treatment is an emotionally charged experience, an important part of survivorship care, and a topic about which limited patient information exists. …”
Get full text
Article -
1102
β-Carboline-α-aminophosphonate Derivative: A Promising Antitumor Agent for Breast Cancer Treatment
Published 2023-05-01Get full text
Article -
1103
Dual antineoplastic and photodynamic effects of methanolic extract of Tecoma stans yellow flowers for cancer treatment
Published 2023-06-01“…Various parts of T. stans have been used in different biological applications, especially in cancer treatment. Photodynamic therapy (PDT) is a promising modality for cancer treatment that depends on the interaction between a photosensitizer, light, and oxygen. …”
Get full text
Article -
1104
-
1105
-
1106
Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment
Published 2022-11-01Subjects: Get full text
Article -
1107
Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial
Published 2010-06-01“…</p> <p>Methods/Design</p> <p>The Physical Activity during Cancer Treatment study is a multicentre randomised controlled trial in 150 breast and 150 colon cancer patients undergoing cancer treatment. …”
Get full text
Article -
1108
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
Published 2021-07-01“…This development starts from non-selective CDK inhibitors to selective CDK4/CDK6 inhibitors, and these have been applied in clinical cancer treatment. However, these inhibitors currently require further development for various hematologic malignancies and solid tumors, based on the results demonstrated. …”
Get full text
Article -
1109
Transanal total mesorectal excision (TaTME) in rectal cancer treatment within an expert center
Published 2023-10-01Get full text
Article -
1110
-
1111
-
1112
A Systematic Review of Molecular Pathway Analysis of Drugs for Potential Use in Liver Cancer Treatment
Published 2023-04-01Get full text
Article -
1113
Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose?
Published 2013-09-01Get full text
Article -
1114
-
1115
Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
Published 2021-07-01“…Platinum-based chemotherapies, such as cisplatin, play a large role in cancer treatment. The development of resistance and treatment toxicity creates substantial barriers to disease control, yet. …”
Get full text
Article -
1116
Understanding Inflammasomes and PD-1/PD-L1 Crosstalk to Improve Cancer Treatment Efficiency
Published 2020-11-01“…In this review, we provide an overview of the crosstalk between inflammasomes and programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) that might explain how these two pathways are mutually dependent, and perhaps why targeting only one of them leads to inefficiency of cancer treatment in some patients.…”
Get full text
Article -
1117
-
1118
Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments
Published 2023-12-01Get full text
Article -
1119
-
1120
Treating sex and gender differences as a continuous variable can improve precision cancer treatments
Published 2024-04-01“…Conclusions Cancer type, patient sex and gender, and TI value provides a novel and patient- specific mechanistic identifier that can be used for realistic sex and gender-adaptations of precision cancer treatment planning.…”
Get full text
Article